Drug intelligence / Profile preview

momordica charantia extract

Development stage
Phase 2
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Momordica charantia extract, commonly known as bitter melon extract, is derived from the fruits of the Momordica charantia plant, which is native to India and other Asian countries, growing in tropical and subtropical regions of Asia, Africa, and the Caribbean. This extract has been traditionally used in various medicinal systems, particularly for managing diabetes and other health conditions. The extract contains several bioactive compounds including charantin (a steroidal saponin with insulin-like properties), polypeptide-p (an insulin-like peptide), vicine, and various phenolic compounds, flavonoids, and triterpenoids[1][6]. These compounds are believed to contribute to its hypoglycemic effects, which have made it popular in traditional medicine for diabetes management[1][2]. The primary mechanism of action appears to be through insulin-like effects that help reduce blood glucose levels. Charantin, one of the main active components, has a molecular weight of 9.7 kDa and chemical properties similar to insulin[6]. The extract may improve glucose tolerance and insulin sensitivity[2]. Traditionally used in various medicinal systems for diabetes management, bitter melon extract has shown moderate hypoglycemic effects in limited clinical studies[2]. Beyond its antidiabetic properties, it has been investigated for potential benefits in treating osteoarthritis, improving athletic performance, and for its antiviral, antineoplastic (anticancer), and immunomodulatory activities[1][2][7].

Brand names
balsam applebalsam pearbitter applebitter cucumberbitter gourdkarelalakwamargosewild cucumber
Other names
bitter melon extractbitter gourd extractkarela extractbalsam pear extractbitter cucumber extract
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on momordica charantia extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on momordica charantia extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call